Background
==========

Brain death (BD) as \"*coma dépassé*\" was first defined by Mollaret and Goulon in 1959 \[[@B1]\], and it remains the medically and legally accepted framework for the diagnosis of death. Death is pronounced on the basis of well-defined clinical examinations followed by confirmatory technical tests. Recent improvements in life support technology and critical care management make it possible to maintain the patient\'s vital functions after BD. The question whether to offer life support to brain-dead patients and how long it should be provided has become a controversial ethical issue. The issue is still more complex when BD occurs during pregnancy. Of course, the incidence of BD in pregnant women is very low and there are only few case reports. As shown by Suddaby *et al*. \[[@B2]\], of 252 brain-dead patients, only 5 (2.8%) cases involved pregnant women between 15 and 45 years of age.

When confronted with BD in a pregnant woman, physicians must primarily focus on saving the life of the fetus, and therefore the treatment protocol should give special recommendations on how to support the mother in a way that she can deliver a viable and healthy child. After delivery, brain-dead pregnant women may also be candidates for organ donation. Therefore, two aspects must be considered in case of maternal BD: supporting the fetus until successful delivery and, if possible, supporting the brain-dead mother as an organ donor. Hence, if the mother and the fetus are regarded as two distinct organisms, maintaining the vital functions of a brain-dead pregnant patient may be ethically justifiable to support both the birth of a child and possible organ donation. In such a situation, various clinical disciplines such as neurosurgery, intensive care medicine, obstetrics, neonatology, anesthesiology, transplantation surgery and an ethics committee should work together to minimize maternal and fetal morbidity as well as mortality.

Since only a few reported cases are to be found in the medical literature, most approaches to managing a brain-dead mother remain experiential and relatively little publicized. In this article, we review the available cases of prolonged somatic support in brain-dead pregnant women and analyze when and under which circumstances the pregnancy should be maintained and what challenges are to be faced. To present a protocol to support such patients, we discuss the management of the brain-dead mother and fetus, related recommendations and legal and ethical issues.

Methods
=======

Search strategy
---------------

We performed a systematic review of Medline (1975-2010), EMBASE (1982-2010) and the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 1, 2010) for relevant citations. Key words used in electronic searching included \"maternal brain death,\" \"pregnancy,\" \"brain death,\" \"management of brain death\" and \"fetal monitoring.\" Reference lists of retrieved relevant articles were screened for other studies. Additionally, to include all existent studies, we also contacted experts in the related fields of brain death and pregnancy.

Study selection and data extraction
-----------------------------------

All studies which reported at least one case of maternal brain death during pregnancy were eligible for inclusion. We excluded studies dealing with pregnancy in a persistent vegetative state because brain death adds complexities to pregnancy that are very different from a persistent vegetative state, calling for different medical management and obstetric strategies, as well as other legal and ethical considerations. Furthermore, we excluded studies which only discussed ethical and legal issues and studies providing insufficient data. There were no language restrictions. One reviewer (ME) screened all titles and abstracts to assess whether they were potentially eligible for inclusion and whether full text was required. Then abstracts and full texts for all potentially eligible studies were reviewed by two researchers (ME and EK), who independently evaluated these articles and extracted their data. Any disagreement during study selection and the data extraction process was resolved by discussion with a third author (AM). According to our search of the medical literature, 30 cases of maternal BD (19 case reports and 1 case series) were reported between 1982 and 2010. The collected data included the age of the mother, the cause of BD, maternal medical complications, gestational age at BD, duration of life support and gestational age at delivery. In addition, we evaluated the indication of delivery, mode of delivery, neonatal outcome and organ donation by the mothers, as well as the transplant outcome. In our analysis, we particularly focused on the critical care management of brain-dead mothers such as respiratory and cardiovascular support, endocrinology and thermoregulation, nutritional support and organ donation, as well as aspects of obstetric management, including fetal monitoring.

Statistical analysis
--------------------

The statistical analysis was performed using SPSS 14.0 software for Windows (Stata Corp., College Station, TX, USA). All statistical data regarding maternal age, duration of maternal support, gestational age and fetal birthweight were expressed as means.

Results
=======

Figure [1](#F1){ref-type="fig"} summarizes the process of literature identification and selection. According to our search, between 1982 and 2010, 19 case reports and 1 case series were published. In Table [1](#T1){ref-type="table"}, we summarize the 30 reported cases of extended maternal life support after BD with pregnancy and the resulting neonatal outcomes.
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###### 

An overview of the reported cases of extended maternal somatic support after brain death (BD) including neonatal outcomes\*

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                             Year/\        Age of mother (yr)    Cause\                             Gestational age\   Duration of life support (days)   Maternal\                                                                                 Indication\                                     Gestational age\   Mode\            Neonatal\                                          Organ\            Transplant\
                                    country                             of\                                at BD\                                               medical\                                                                                  for\                                            at delivery\       of\              outcome                                            procurement       outcome
                                                                        BD                                 (wk)                                                 complications                                                                             delivery                                        (wk)               delivery                                                                              
  --------------------------------- ------------- --------------------- ---------------------------------- ------------------ --------------------------------- ----------------------------------------------------------------------------------------- ----------------------------------------------- ------------------ ---------------- -------------------------------------------------- ----------------- ----------------------------------------------------------
  Dillon *et al*. \[[@B48]\]        1982/\        24                    Meningitis                         23                 24                                Thermovariability,\                                                                       Fetal distress                                  26                 C/S              Female, 930 gr,\                                   No                \-
                                    USA                                                                                                                         DI                                                                                                                                                                            Apgar 8/8, IRDS                                                      

  Heikkinen *et al*. \[[@B49]\]     1985/\        31                    ICH\                               21                 71                                Thermovariability, pneumonia, hypotension, DI, bacteremia, panhypopituitarism             Maternal\                                       31                 C/S              Male, 1600 gr,\                                    No                \-
                                    Finland                             SAH                                                                                                                                                                               blood pressure fluctuation                                                          Apgar 6/7,\                                                          
                                                                                                                                                                                                                                                                                                                                              IRDS\                                                                
                                                                                                                                                                                                                                                                                                                                              Normal at 8 mo.                                                      

  Field *et al*.\                   1988/\        27                    CNS mass                           22                 63                                Thermovariability, hypotension, panhypopituitarism, DI, ARDS, UTI, bacteremia             Septicemia,\                                    31                 C/S              Male, 1440 gr\                                     No                \-
  \[[@B14]\]                        USA                                                                                                                                                                                                                   Growth retardation                                                                  Apgar 8/8,\                                                          
                                                                                                                                                                                                                                                                                                                                              IRDS,\                                                               
                                                                                                                                                                                                                                                                                                                                              normal at 18 mo.                                                     

  Bernstein *et al*. \[[@B33]\]     1989/\        30                    Traumatic brain injury             15                 107                               Thermovariability, panhypopituitarism, pneumonia,\                                        Suspicious for\                                 32                 C/S              Male, 1555 gr\                                     No                \-
                                    USA                                                                                                                         DI                                                                                        fetal distress                                                                      Apgar 6/9,\                                                          
                                                                                                                                                                                                                                                                                                                                              Mild hyperbilirubinemia, Normal at 11 mo.                            

  Antonini *et al*.\                1992/\        25                    ICH                                15                 49                                Panhypopituitarism,\                                                                      Maternal death due to progressive hypotension   Not applicable     Not\             Intrauterine death                                 No                \-
  \[[@B50]\]                        Italy                                                                                                                       Pneumonia\                                                                                                                                                   applicable                                                                            
                                                                                                                                                                UTI,\                                                                                                                                                                                                                                              
                                                                                                                                                                Hemodynamic instability\                                                                                                                                                                                                                           
                                                                                                                                                                Hyperglycemia\                                                                                                                                                                                                                                     
                                                                                                                                                                anemia                                                                                                                                                                                                                                             

  Nettina *et al*. \[[@B51]\]       1993/\        31                    ICH                                27                 44                                hypothermia; hypotension; decubitus ulcer,\                                               Maternal hypotension                            33                 C/S              Male, 2083 gr\                                     Yes               N.A.
                                    USA                                                                                                                         DI, pneumonia                                                                                                                                                                 Apgar 9                                                              

  Anstotz\                          1993/\        18                    Accident                           13                 38                                Severe infection                                                                          Not applicable                                  Not applicable     Not\             Spontaneous abortion\                              No                \-
  \[[@B52]\]                        Germany                                                                                                                                                                                                                                                                                  applicable       at 19 weeks\                                                         
                                                                                                                                                                                                                                                                                                                                              (autopsy refused)                                                    

  Beguin\                           1993/\        20                    ICH                                20                 3                                 No complication                                                                           Not applicable                                  Not applicable     Not applicable   Intrauterine death                                 Yes               N.A.
  \[[@B53]\]                        Switzerland                                                                                                                                                                                                                                                                                                                                                                    

  Wuermeling\                       1994/\        18                    Traffic accident                   14                 N.A                               infection                                                                                 N.A.                                            N.A.               N.A.             Intrauterine death                                 N.A.              \-
  \[[@B54]\]                        Germany                                                                                                                                                                                                                                                                                                                                                                        

  Iriye *et al*.\                   1995/\        35                    ICH\                               30                 2                                 hypotension                                                                               Maternal\                                       30                 C/S              Male, 1610gr,\                                     No                \-
  \[[@B55]\]                        USA                                 after cocaine                                                                                                                                                                     blood pressure fluctuation                                                          Apgar 7/8                                                            

  Vives *et al*.\                   1995/\        25                    Meningitis                         27                 1,5                               Hypotension,\                                                                             Maternal hypotension                            27                 C/S              Male, 1150 gr,\                                    No                \-
  \[[@B56]\]                        Spain                                                                                                                       sepsis,\                                                                                                                                                                      Apgars 7/10,\                                                        
                                                                                                                                                                DIC,\                                                                                                                                                                         IRDS,\                                                               
                                                                                                                                                                cardiac arrhythmia                                                                                                                                                            normal at 14 mo.                                                     

  Catanzarite *et al*. \[[@B32]\]   1997/\        25                    ICH                                25                 25                                Hypotension, ARDS, DI, panhypopituitarism, pneumonia,                                     Fetal distress                                  28                 C/S              Male, 1315 gr\                                     No                \-
                                    USA                                                                                                                                                                                                                                                                                                       Apgar 3/7\                                                           
                                                                                                                                                                                                                                                                                                                                              fungemia                                                             

  Lewis *et al*.\                   1997/\        20                    SAH                                25                 54                                Hypotension, DI\                                                                          Sufficient fetal\                               32                 C/S              Not available                                      Yes               No complication after 1 year
  \[[@B42]\]                        USA                                                                                                                         bacteremia,                                                                               lung maturity                                                                                                                                            

  Suddaby *et al*.\                 1998/\        Range from\           5 cases:\                          Range from\        N.A                               Hypotension\                                                                              N.A                                             N.A                N.A              N.A                                                In five mothers   Of 25 donated organs (5 heart, 5 liver,\
  \[[@B2]\]                         USA           15 to 45 (11 cases)   ICH\                               2 to 40                                              DI\                                                                                                                                                                                                                                                10 kidney,\
                                                                        1 case: Hematoma\                                                                       Anemia\                                                                                                                                                                                                                                            5 pancreas), only one liver and one pancreas graft lost.
                                                                        1 case: Aneurysm\                                                                       Hypernatremia\                                                                                                                                                                                                                                     
                                                                        1 case:\                                                                                Hyperglycemia\                                                                                                                                                                                                                                     
                                                                        Amniotic embolus\                                                                       Hypocalcemia\                                                                                                                                                                                                                                      
                                                                        1 case:\                                                                                hyperchloremia                                                                                                                                                                                                                                     
                                                                        Glioblastoma\                                                                                                                                                                                                                                                                                                                              
                                                                        1 case:\                                                                                                                                                                                                                                                                                                                                   
                                                                        Cardiac arrest\                                                                                                                                                                                                                                                                                                                            
                                                                        1 case:\                                                                                                                                                                                                                                                                                                                                   
                                                                        Gunshot                                                                                                                                                                                                                                                                                                                                    

  Spike\                            1999/\        20                    ICH                                16                 100                               Panhypopituitarism, DI, Thermovariability\                                                Unusual pattern of the placenta in ultrasound   31                 C/S              Male, 1440gr\                                      No                \-
  \[[@B57]\]                        USA                                                                                                                         Hypotension                                                                                                                                                                   Apgar 8/8                                                            

  Beca *et al*.\                    1999/\        26                    ICH                                17                 5                                 Hemodynamic instability\                                                                  Maternal death due to resistance\               Not applicable     Not applicable   Intrauterine death                                 No                \-
  \[[@B58]\]                        Chile                                                                                                                       Fiber                                                                                     hypotension                                                                                                                                              

  Lane *et al*.\                    2004/\        26                    Cerebral venous sinus thrombosis   13                 8                                 DI,\                                                                                      Not applicable                                  Not applicable     Not applicable   Intrauterine death\                                Yes               N.A.
  \[[@B59]\]                        Ireland                                                                                                                     pneumonia,\                                                                                                                                                                   at 14 weeks                                                          
                                                                                                                                                                Hyper- and hyponatraemia                                                                                                                                                                                                                           

  Hussein *et al*.\                 2006/\        33                    ICH                                26                 14                                Hypertension, bradycardia,\                                                               Progressive oligohydraminos                     28                 C/S              Male, 1285 gr,\                                    No                \-
  \[[@B60]\]                        UK                                                                                                                          Chest infection,\                                                                                                                                                             breathing difficulties\                                              
                                                                                                                                                                Hyperglycemia,\                                                                                                                                                               Normal at 24 mo.                                                     
                                                                                                                                                                serum cortisol reduced                                                                                                                                                                                                                             

  Souza *et al*.\                   2006/\        40                    ICH                                25                 25                                Panhypopituitarism, hyperglycemia DI, hypotension, bradycardia, hypothermia, pneumonia,   Progressive oligohydraminos,\                   29                 C/S              Male, 815 gr\                                      Yes               N.A.
  \[[@B61]\]                        Brazil                                                                                                                                                                                                                brain sparring                                                                      Apgars:9/10\                                                         
                                                                                                                                                                                                                                                                                                                                              Normal at 3 mo.                                                      

  Mejia *et al*.\                   2008/\        29                    ICH                                17                 56                                DI\                                                                                       Maternal hypotension\                           25                 C/S              450 gr\                                            No                \-
  \[[@B62]\]                        Argentina                                                                                                                   Panhypopituitarism,\                                                                      &\                                                                                  Premature Birth complication, Candida infection\                     
                                                                                                                                                                Pneumonia\                                                                                Cardiac arrest                                                                      Died at day 30                                                       
                                                                                                                                                                UTI,\                                                                                                                                                                                                                                              
                                                                                                                                                                Hemodynamic instability                                                                                                                                                                                                                            
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*ICH, intracranial hemorrhage; SAH, subarachnoid hemorrhage; DI, diabetes insipidus; ARDS, acute respiratory distress syndrome; UTI, urinary tract infection; C/S, cesarean section; IRDS, infant respiratory distress syndrome; N.A: not available.

Maternal and obstetric outcome
------------------------------

In the 30 reported cases, the maternal mean age at the time of BD was 26.5 years. Only three mothers were in the high-risk pregnancy category (age \<18 or age \>35 yr) with respect to their age. Two mothers were 18 years old and a third one was 40 years old at the time of pregnancy. Trauma was the cause of BD in 4 of 30 mothers, and the other 26 died of nontraumatic brain injuries. The mean duration of maternal support was 38.3 days (range, 2-107 days). In two cases, children were delivered on the second day after BD was diagnosed. Conversely, in two reports, mothers were supported for more than 100 days before delivery. The mean gestational age at the time of BD was 22 weeks (range, 1-40 wk). In 10 of 19 reported cases, the baby was delivered later than week 28. The mean gestational age at delivery was 29.5 weeks (range, 26-33 wk). During extended life support, patients developed several complications, including infection, hemodynamic instability, diabetes insipidus (DI), panhypopituitarism, poikilothermia, metabolic instability, acute respiratory distress syndrome and disseminated intravascular coagulation (Table [1](#T1){ref-type="table"}). The indications for delivery in all reported cases were maternal or fetal difficulties, including maternal hemodynamic instability (seven cases), fetal distress (three cases), oligohydramnion (two cases), intrauterine growth retardation (one case) and abnormal pattern of the placental structure (one case). In two cases in which maternal BD began at week 13 of gestational age, spontaneous abortion occurred at weeks 13 and 19. In four cases, there was intrauterine death. A cesarean section was the mode of delivery in all cases which resulted in live-born fetuses (Table [1](#T1){ref-type="table"}).

Fetal and neonatal outcome
--------------------------

In 12 (63%) of 19 reported cases, the prolonged somatic support led to the delivery of a viable child. We did not find any information about the fate of the fetuses in the published case series. Children who were born included 1 female and 10 male infants. No information regarding sex was given about one infant. The average birthweight was 1,384 g (range, 815-2,083 g), and the mean Apgar score was 7 and 8 at 1 and 5 minutes, respectively. Congenital defects were reported for only one infant, who was diagnosed with fetal hydantoin syndrome resulting from previous chronic phenytoin usage by the mother. Four infants required temporary mechanical ventilation because of neonatal respiratory distress syndrome or pneumonia. Fungemia was diagnosed in one infant, and he was treated with amphotericin B. However, not every infant was sufficiently followed to determine the long-term effects of prolonged maternal life support. Postnatal follow-up up to 24 months was available only for six infants. All of them developed normally and apparently had no problems related to their exceptional intrauterine circumstances (Table [1](#T1){ref-type="table"}).

Organ procurement and transplant outcome
----------------------------------------

In three reported cases after successful delivery, organ donation from the brain-dead mother was carried out. In two cases, organ procurement was accomplished after the intrauterine death of the fetus. In yet another five cases, organ donation was performed, but no report about the status of the fetus was provided. In six patients, consent was given by the patient\'s family to donate heart, lung, liver, pancreas and kidneys. In four donors, no information was given concerning donated organs. The 1-year graft survival in the reported cases was excellent. Only one liver and one pancreas were lost in two patients owing to their primary nonfunction. Finally, in all cases, maternal somatic support was ended either after delivery or after organ donation (Table [1](#T1){ref-type="table"}).

Discussion
==========

Clinically, following the onset of BD, it is possible to sustain a brain-dead mother\'s somatic functions over a longer period. Manifold physiological changes occurring during pregnancy and brain death, as well as the prolonged hospital stay after BD, present enormous challenges, however, both for the treating clinicians and for the family. The important question is from which gestational age onward should the pregnancy be supported? At present, it seems that there is no clear lower limit to the gestational age which would restrict the physician\'s efforts to support the brain-dead mother and her fetus. As reported by *Slattery et al*. \[[@B3]\], a fetus born before 24 weeks of gestation has a limited chance of survival. At 24, 28 and 32 weeks, a fetus has approximately a 20-30%, 80% and 98% likelihood of survival with a 40%, 10% and less than 2% chance of suffering from a severe handicap, respectively. Therefore, depending on maternal stability and fetal growth, the decision must be made on an individual basis. According to our findings, prolonged somatic support can lead to the delivery of a viable child with satisfactory Apgar score and birthweight. Such children can also develop normally without any problems resulting from their intrauterine conditions. Furthermore, after the delivery, mothers could be considered as potential organ donors. In Figure [2](#F2){ref-type="fig"}, we summarize the recommendations for the critical care management of brain-dead pregnant women. This schema is not a definitive guideline, because the technical support and the experience of the responsible medical team must also be taken under consideration. Also, the number of reported cases is too small to define the rate at which intensive care support of the brain-dead mother can result in a healthy infant. The percentage of successful cases cannot be determined, because there are no reports describing failure of intensive maternal support from all medical centers. Finally, it cannot be established whether a relative infrequency of cases such as those that we found in the published literature reflects the rarity of the event, perfect success in all prior situations, reluctance to initiate intensive efforts required to support the brain-dead patient or simply publication bias.
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However, we maintain that the management of a brain-dead pregnant woman should follow the existent standards, guidelines and recommendations both for nontraumatic therapy for the fetus and organ-preserving treatment for the donor \[[@B4]-[@B6]\]. What follows here is the summary of these guidelines and recommendations.

Cardiovascular support
----------------------

In the initial phase of BD, tachycardia was detected in less than half of the patients \[[@B7],[@B8]\]. However, subsequently the heart rate slowed in all of these patients as factors such as hypothermia and subclinical myocardial hypoxia antagonized the sympathetic activation occurring during the initial phase of BD \[[@B7]\]. Hypertension in this situation is a rare, usually self-limiting event. In prolonged hypertension, short-acting substances such as urapidil or nitroprusside were applied \[[@B9],[@B10]\]. Typically, at some point, BD patients also develop hypotension \[[@B9]\]. The initial treatment for hypotension consists of aggressive fluid replacement, which is usually done with crystalloids such as lactated Ringer\'s solution in normal (0.9%) or half-normal (0.45%) saline solutions. Recent studies suggest that to keep intravascular volume and colloid oncotic pressure within physiological ranges \[[@B9]\], hydroxyethyl starch can also be applied in case of a negative effect on the renal graft function \[[@B11]\]. However, it must be kept in mind that low oncotic pressure and hypoalbuminemia can cause pulmonary edema \[[@B12],[@B13]\]. Field *et al*. \[[@B14]\] recommended that in case of pulmonary edema a Swan-Ganz catheter be used to differentiate cardiogenic pulmonary edema from acute respiratory distress syndrome (ARDS) and to guide fluid management. In addition, extensive hemodynamic monitoring such as Pulscontour Continuous Cardiac Output (PiCCO™) should be considered \[[@B4],[@B15]\]. Fluid-resistant hypotension can be treated using continuous intravenous dopamine receptor agonists, which should be titrated until a mean arterial pressure of 80 to 110 mmHg is reached \[[@B16]\].

Respiratory support
-------------------

In maternal BD, special attention needs to be paid to mechanical ventilation. To facilitate the elimination of carbon dioxide from the fetus and as a result of the progesterone effect on the respiratory center, the pregnant mother develops hypocarbia mediated by an increase in tidal volume and respiratory rate. Hypocarbia is compensated by an increase in excretion of bicarbonates by the kidneys \[[@B17]\]. Maternal carbon dioxide tensions, a tidal volume and respiratory rate should be maintained in the normal pregnancy range of 28 to 31 mmHg, 6 to 8 mL/kg and 10 to 12/min, respectively \[[@B18]\]. The fraction of inspired oxygen should be kept in a range maintaining the arterial oxygen saturation above 90%.

Endocrine support
-----------------

Seventy-eight percent of brain-dead patients who were kept alive for more than a few days developed central diabetes insipidus (DI) resulting from posterior pituitary gland failure \[[@B19]\]. Administration of vasopressin and aggressive volume replacement should be performed for the treatment of DI \[[@B4]\]. Howlett *et al*. \[[@B20]\] reported a decrease in serum triiodothyronine (T3) in 81% and in serum thyroxin (T4) in 29% of BD dead organ donors. Therefore, especially in brain-dead pregnant women T3/T4 substitution should be adjusted according to laboratory examinations. Adrenal insufficiency causes hypotension and should be treated with methylprednisolone. To avoid prolonged exposure of the fetus to glucocorticoids during maternal somatic support, prednisone or methylprednisone should be used, as they do not readily cross the placenta \[[@B21]\]. Furthermore, since hyperglycemia is also observed during BD as a result of stress-related peripheral insulin resistance, insulin substitution may be needed to achieve normoglycemia \[[@B12]\].

Thermoregulation
----------------

According to Smith *et al*. \[[@B22]\], the majority of brain-dead patients develop hypothermia. It is recommended that the patient be rewarmed passively using warming blankets or by warming of fluids. Following infections, brain-dead patients might also develop hyperthermia. In general, the inability to maintain body temperature and poikilothermia (body temperature that is dependent on the environment\'s temperature) accompany brain-dead patients \[[@B23],[@B24]\].

Nutritional support
-------------------

The nutritional needs of a pregnant woman before and after BD are not the same. Basal energy expenditure (BEE) in pregnancy is 655 Kcal + (9.6 × weight (kg) + \[1.8 × height (cm) \-- 4.7 age (year)\]) \[[@B25]-[@B27]\]. A weight gain of 10 to 15 kg accompanies a normal pregnancy \[[@B12]\]. A brain-dead pregnant woman will expend about 75% of a healthy pregnant woman\'s BEE \[[@B27]\]. Nutritional support should be calculated by maternal serum alimentary values, the weight of the mother and the growth of the fetus. Owing to reduced motility of the gastrointestinal tract in brain-dead patients, special attention should be paid to the management of gastric reflux. Total parenteral nutrition (TPN) during BD in pregnant mothers needs to support a positive nitrogen balance, maternal weight gain, and normal fetal growth and birthweight \[[@B28]\]. The recommended daily allowance for protein during pregnancy is 0.8 g kg^-1^day^-1^(the normal intake for an average healthy adult) plus an additional 1.3, 6.1 or 10.7 g kg^-1^day^-1^for the first, second or third trimesters, respectively \[[@B29],[@B30]\]. In addition, 20-25% of nonprotein calories should be from fat \[[@B29]\].

Infection
---------

There are three sources of infection which should be taken into account during prolonged somatic support: ventilators causing recurrent pneumonia, urinary catheters resulting in bladder and kidney infections and intravascular catheters as a source of septicemia \[[@B31]\]. The majority of reported organisms were typical of nosocomial intensive care unit infections such as *Staphylococcus aureus*, *Actinobacter*, *Pseudomonas*, *Hemophilus influenza*and fungal pathogens \[[@B32],[@B33]\]. These infections are usually resistant to antibiotics, and their treatment is challenging. Maternal infections must be treated aggressively with the most effective substances, rather than opting for using substances safe for the fetus, which in turn may not effectively treat the infection \[[@B34]-[@B36]\].

Prophylactic anticoagulation
----------------------------

The risk of developing deep vein thrombosis is greater during pregnancy because of immobility and flaccid paralysis following BD. Recommended is prophylactic anticoagulation as it is efficacious for the mother and safe for the fetus. For venous thromboembolic disease treatment or prophylaxis during pregnancy, low molecular weight heparin appears to be as safe and effective as unfractionated heparin \[[@B37]\].

Obstetric considerations
------------------------

In maternal BD, it is recommended to screen the mother\'s serum and to examine carefully the fetus by ultrasound to establish that there are no malformations or pathologic findings in the fetal development and no chromosomal abnormalities. In cases with uncertain findings, amniocentesis should be discussed with family members, since the results of these screenings may influence their decisions \[[@B17]\]. In addition, laboratory tests including complete blood cell count, electrolytes such as Na^+^, Ca^2+^, K^+^, creatinine, urea, liver enzymes, retinol-binding proteins, albumin, prealbumin, transferrin and urine analysis should be periodically performed. After 24 weeks of gestation, glucocorticoids should be administered for fetal lung maturation and prophylaxis of fetal respiratory distress syndrome \[[@B38],[@B39]\]. To prevent preterm uterine contractions, in particular in the early weeks of gestation when no fetal lung maturation is yet provided, tocolytic interventions may be needed. Calcium channel blockers and prostaglandin inhibitors are effective and well tolerated and are therefore preferred to β-mimetic agents \[[@B37],[@B40]\]. A prolongation of the pregnancy should continue until at least 26 weeks of gestation with a possible second application of glucocorticoids. If maternal and fetal status remain stable, further prolongation of the pregnancy until at least 28 weeks of gestation should be attempted. According to the reported literature, after 32 weeks of gestation and under glucocorticoid-induced fetal lung maturity, no further prolongation of a pregnancy seems necessary. The optimal method of delivery in prolonged maternal somatic support is by cesarean section, as it ensures the least traumatic birth for the fetus. The optimal timing for a cesarean section can be estimated by amniocentesis assessing fetal lung maturity \[[@B41]\].

Fetal and neonatal considerations
---------------------------------

The gestational age and the condition of the fetus, above all lung maturity, are the two most important factors affecting fetal outcome. The majority of studies reported routine and complex fetal monitoring such as daily fetal heart rate monitoring using cardiotocography and nonstress testing. Serial ultrasound examinations to evaluate the fetoplacental unit, including biometric estimations as well as morphologic studies on the placental structure and the amnion fluid, should be performed weekly to assess intrauterine fetal growth \[[@B39],[@B42]-[@B44]\].

Organ donation and transplant outcome
-------------------------------------

After the delivery of the fetus, a brain-dead mother should be considered as a potential organ donor. Multiorgan instabilities and extensive critical care therapy lasting for weeks may have endangered the organs and caused complications in the recipients. Nevertheless, if one or more organs are still functioning at the time of delivery, the feasibility of organ donation in such catastrophic cases should not be ignored. As reported by Suddaby *et al*. \[[@B2]\] in a retrospective review of 252 brain-dead potential donors from 1990 to 1996, five of seven pregnant women functioned as organ donors for 20 transplant recipients. For all of those patients, excellent patient and graft outcomes were reported.

Ethical and legal issues
------------------------

Many ethical and legal questions arise in cases of maternal BD. Although it was not the focus of this review, we briefly discussed various aspects of ethical and legal issues such as \"the mother\'s body as a cadaveric incubator,\" \"mother as the organ donor and fetus as the recipient\" and the concern for \"possible damages to the fetus\" \[[@B31],[@B45]\]. Some professionals believe that it is not ethically acceptable to maintain the mother\'s body after BD to use it as a \"fetal container.\" Such a decision should not be simply assumed, but it must be debated. If the mother is to be considered a \"cadaveric incubator\" with no autonomous rights, the rights of the fetus should legally prevail. Another argument claims that the prolonged somatic support itself is actually organ donation with the fetus as the recipient. In that case, if the mother had previously indicated a wish to donate her organs, it would be appropriate to proceed with the extended somatic support. Finally, some believe that strategies used to maintain maternal somatic function are still in the experimental stage. Not every adverse effect of medication used on the fetus during an extended somatic support is known. The next of kin must therefore be informed about the existing life maintenance strategies and the possible damages they may cause to the fetus. Psychological consultation should certainly be beneficial in this situation.

Since such catastrophic cases are so infrequent, the mother\'s wish is in effect rarely known. For this reason, it is strongly suggested to engage the family in the planning of the care. The physician and transplant coordinator should not impose all available procedures against the wishes of the family. Sperling *et al*. \[[@B46]\] suggested that questions be answered on a case-by-case basis with the involvement of the hospital\'s ethics committee. One also needs to consider that while nowadays somatic support in the case of maternal BD is technically possible, there is still no legal document which asks a pregnant woman about the fate of her unborn child in the event of BD. It is highly recommended that this question be added to the advance directives of any woman of childbearing age and routinely discussed in standard prenatal interviews \[[@B47]\].

Conclusions
===========

At present, BD is a medically and legally accepted event allowing a pronouncement of death. Taking into account that in maternal BD two organisms are involved, the mother and the fetus, a decision whether to maintain the mother\'s vital functions to allow fetal survival is also an ethical and legal issue. The goal of prolonged maternal somatic support is to deliver a viable and healthy infant with a beneficial long-term outcome. From the medical point of view, the management of a brain-dead pregnant woman should follow the common standards, guidelines and recommendations for organ-preserving therapy. In some situations, however, the mother needs special medical support and interventions which differ from somatic support in nonpregnant BD patients. Both after a successful delivery and in the case of fetal abortion, the mother can also be considered as an organ donor. In general, we recommend that there be no clear lower limit to the gestational age which would restrict the physician\'s efforts to support the brain-dead mother and her fetus. A meeting of the neurosurgical, critical care, obstetric, neonatal, transplant and ethical staff, along with the patient\'s family, should collectively make a decision about future treatment steps. Since currently there are still only a limited number of cases describing the management of extended maternal somatic support after brain death, the current recommendations should be continuously reassessed and adapted along with the growing experience and knowledge. For such serious and rare cases as described here, it would be advisable from a clinical point of view to establish an international registry network of BD pregnant patients, which could help to gather further experience. We also think that from the practical point of view, it would be possible to establish such a registry and this network could become a part of routine clinical usage in all neurosurgery and intensive care centers.
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